首页> 外文期刊>Human Molecular Genetics >Mutation in NDUFA13/GRIM19 leads to early onset hypotonia, dyskinesia and sensorial deficiencies, and mitochondrial complex I instability
【24h】

Mutation in NDUFA13/GRIM19 leads to early onset hypotonia, dyskinesia and sensorial deficiencies, and mitochondrial complex I instability

机译:NDUFA13 / GRIM19中的突变导致早期发作性肌张力低下,运动障碍和感觉缺陷,以及线粒体复合体I不稳定

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mitochondrial complex I (CI) deficiencies are causing debilitating neurological diseases, among which, the Leber Hereditary Optic Neuropathy and Leigh Syndrome are the most frequent. Here, we describe the first germinal pathogenic mutation in the NDUFA13/GRIM19 gene encoding a CI subunit, in two sisters with early onset hypotonia, dyskinesia and sensorial deficiencies, including a severe optic neuropathy. Biochemical analysis revealed a drastic decrease in CI enzymatic activity in patient muscle biopsies, and reduction of CI-driven respiration in fibroblasts, while the activities of complex II, III and IV were hardly affected. Western blots disclosed that the abundances of NDUFA13 protein, CI holoenzyme and super complexes were drastically reduced in mitochondrial fractions, a situation that was reproduced by silencing NDUFA13 in control cells. Thus, we established here a correlation between the first mutation yet identified in the NDUFA13 gene, which induces CI instability and a severe but slowly evolving clinical presentation affecting the central nervous system.
机译:线粒体复合物I(CI)的缺乏正在引起令人衰弱的神经系统疾病,其中以Leber遗传性视神经病变和Leigh综合征最为常见。在这里,我们描述了NDUFA13 / GRIM19基因编码CI亚基的第一个生发性致病突变,出现在两个患有早发性肌张力低下,运动障碍和感觉缺陷(包括严重的视神经病变)的姐妹中。生化分析显示,患者肌肉活检中CI酶活性急剧下降,成纤维细胞中CI驱动的呼吸力降低,而复合物II,III和IV的活性几乎未受影响。 Western印迹显示线粒体组分中NDUFA13蛋白,CI全酶和超级复合物的丰度大大降低,这种情况通过在对照细胞中沉默NDUFA13得以重现。因此,我们在这里建立了NDUFA13基因中尚未发现的第一个突变,该突变会诱导CI不稳定,并且影响中枢神经系统的严重但缓慢发展的临床表现之间存在相关性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号